Botanical species · safety record

Cistus monspeliensis

The EFSA Compendium of Botanicals holds 13 constituent measurements for Cistus monspeliensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cistus monspeliensis L.

13Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Labdane diterpenes5
  • Clerodane-type diterpenes4
  • (-)-camphor1
  • 1,8-cineole1
  • Eugenol1
  • Gallic acid1

Plant parts

  • Leaves6
  • Fruit unspecified4
  • Aerial part of plants3

Preparations

  • Solvent extraction7
  • Essential oil6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Clerodane-type diterpenesFruit unspecifiedEssential oil6.6 PercentGC-MSResolve DOI
Clerodane-type diterpenesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Clerodane-type diterpenesLeavesSolvent extraction50 PercentGC-MSResolve DOI
Clerodane-type diterpenesFruit unspecifiedSolvent extraction62.5 PercentGC-MSResolve DOI
Labdane diterpenesFruit unspecifiedEssential oil6.6 PercentGC-MSResolve DOI
Labdane diterpenesLeavesSolvent extraction16.6 PercentGC-MSResolve DOI
Labdane diterpenesFruit unspecifiedSolvent extraction25 PercentGC-MSResolve DOI
Labdane diterpenesLeavesEssential oil15.38 PercentGC-MSResolve DOI
Labdane diterpenesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
(-)-camphorLeavesEssential oil1.5 PercentGC-MSNo resolvable identifier
1,8-cineoleLeavesEssential oil8.8 PercentGC-MSNo resolvable identifier
EugenolLeavesEssential oil1.5 PercentGC-MSNo resolvable identifier
Gallic acidAerial part of plantsSolvent extraction8.14 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Angelopoulou, D., Demetzos, C., Dimas, C., Perdetzoglou, D., Loukis, A. Essential oils and hexane extracts from leaves and fruits of Cistus monspeliensis. Cytotoxic activity of ent-13-epi-manoyl oxide and its isomers . Planta medica, 2001, vol. 67, no. 2, p. 168-171. DOI
  2. Viuda-Martos, Manuel., Sendra, Esther., Perez-Alvarez, Jose A., Fernandez-Lopez, Juana., Amensour, Mahassine., Abrini, Jamal. Identification of Flavonoid Content and Chemical Composition of the Essential Oils of Moroccan Herbs: Myrtle (Myrtus communis L.), Rockrose (Cistus ladanifer L.) and Montpellier cistus (Cistus monspeliensis L.) . Journal of essential oil research, 2011, vol. 23, no. 2, p. 1-9.
  3. Fokialakis, Nikolas., Kalpoutzakis, Eleftherios., Tekwani, Babu Lal., Skaltsounis, Alexios Leandros., Duke, Stephen Oscar. Antileishmanial activity of natural diterpenes from Cistus sp and semisynthetic derivatives thereof. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, vol. 29, no. 8, p. 1775-1778. DOI
  4. Santagati, Natale Alfredo., Salerno, Loredana., Attaguile, Giuseppina., Savoca, Francesca., Ronsisvalle, Giuseppe. Simultaneous determination of catechins, rutin, and gallic acid in Cistus species extracts by HPLC with diode array detection. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, vol. 46, no. 2, p. 150-156.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue